Perrigo announces agreement to divest infant formula business to Meridianmade
PRGO•Perrigo agreed to sell its infant formula business to Meridianmade for up to $175 million. It expects a non-cash impairment charge of $275 million to $375 million in the fourth quarter of 2026, with closing expected in the first half of 2027, subject to regulatory approvals.
1. Sale agreement
Perrigo agreed to divest its infant formula business to Meridianmade for up to $175 million. The deal is expected to close in the first half of 2027, subject to regulatory approvals.
2. Expected charge
Perrigo expects a non-cash impairment charge of $275 million to $375 million in the fourth quarter of 2026. The company said the deal is expected to significantly reduce future capital expenditure requirements.
